VAN WIJMEERSCH, Bart

Email Alert RSS Feed

Profile

Full Name
VAN WIJMEERSCH, Bart
Email
bart.vanwijmeersch@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 141-160 of 187 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1412017Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammationVANHEUSDEN, Marjan; BROUX, Bieke; Welten, Suzanne P. M.; PEETERS, Liesbet; Panagioti, Eleni; VAN WIJMEERSCH, Bart; SOMERS, Veerle; STINISSEN, Piet; Arens, Ramon; HELLINGS, NielsJournal ContributionA1
1422016Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis PatientsCLAES, Nele; FRAUSSEN, Judith; VANHEUSDEN, Marjan; HELLINGS, Niels; STINISSEN, Piet; VAN WIJMEERSCH, Bart; Hupperts, Raymond; SOMERS, VeerleJournal ContributionA1
1432016Effects of an individual 12 weeks community located running program on physical capacity, walking, cognitive function, dual tasking and brain volumes and structures in persons with Multiple Sclerosis.FEYS, Peter; MOUMDJIAN, Lousin; Vanhalewyck, F.; WENS, Inez; OP 'T EIJNDE, Bert; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Dufour, A.; Delva, S.; VAN ASCH, PaulJournal ContributionM
1442016Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I).Coles, A. J.; Boyko, A. N.; Cohen, J. A.; De Seze, J.; Fox, E. J.; Havrdova, E.; Hartung, H. -P.; Inshasi, J. S.; McCombe, P.; Selmaj, K. W.; Vermersch, P.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Montalban, X.Journal ContributionM
1452016Durable reduction in MRI disease activity with alemtuzumab in treatment-naive patients with active relapsing-remitting multiple sclerosis: 6-year follow-up of the CARE-MS I studyArnold, D. L.; Barnett, M.; Comi, G.; Giovannoni, G.; Pelletier, D.; Rovira, A.; Schippling, S.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Traboulsee, A.Journal ContributionM
1462016B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responsesFRAUSSEN, Judith; CLAES, Nele; VAN WIJMEERSCH, Bart; VAN HORSSEN, Jack; STINISSEN, Piet; Hupperts, Raymond; SOMERS, VeerleJournal ContributionA1
1472016Effects of teriflunomide treatment on the CD4(+) T-cell receptor repertoire in patients with relapsing-remitting MSKlotz, Luisa; Lindner, Maren; Gross, Catherina C.; Eschborn, Melanie; Posevitz-Fejfar, Anita; Schulte-Mecklenbeck, Andreas; Meuth, S. G.; VAN WIJMEERSCH, Bart; Hupperts, Raymond; Maeurer, M.; Stangel, M.; Lang, M.; Tackenberg, B.; Lysandropoulos, A.; Decoo, D.; Eveslage, M.; Turner, Timothy J.; Jagerschmidt, A.; Bar-Or, Amit; Wiendl, HeinzJournal ContributionM
1482016Durable improvement in clinical outcomes in treatmentnaive patients with relapsing-remitting multiple sclerosis who switched from SC IFNB-1a to alemtuzumab (care-MS I extension study 4-year follow-up)Oreja-Guevara, C.; Alroughani, R.; Brassat, D.; Boyko, A. N.; McCombe, P.; Steingo, B.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Vermersch, P.Journal ContributionM
1492016Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatmentBermel, R.; Comi, G.; Eralinna, J. -P.; Leist, T. P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Bernasconi, C.; Buffels, R.; Csoboth, C.; Han, J.; Musch, B.; Vermersch, P.Journal ContributionM
1502016Brain atrophy by automated MRI reading in long-term natalizumab treated patients: Real world data suggests brain atrophy rates in range of healthy individualsHorakova, Dana; Uher, T.; Vaneckova, M.; Krasensky, J.; Seidl, Z.; van Pesch, V.; Lysandropoulos, A.; VAN WIJMEERSCH, Bart; Ribbens, A.; van Hecke, W.; Dong, Q.; Farkas, M.; Hyde, R.; Koendgen, H.Journal ContributionM
1512016Upper Limb Rehabilitation in People With Multiple Sclerosis: A Systematic ReviewLAMERS, Ilse; MARIS, Anneleen; SEVERIJNS, Deborah; Dielkens, Wouter; Geurts, Sander; VAN WIJMEERSCH, Bart; FEYS, PeterJournal ContributionA1
1522015Associations of Upper Limb Disability Measures on Different Levels of the International Classification of Functioning, Disability and Health in People With Multiple SclerosisLAMERS, Ilse; Cattaneo, Davide; Chen, Christine C.; Bertoni, Rita; VAN WIJMEERSCH, Bart; FEYS, PeterJournal ContributionA1
1532015IL-15 Amplifies the Pathogenic Properties of CD4+CD28- T Cells in Multiple SclerosisBROUX, Bieke; Mizee, Mark R.; VANHEUSDEN, Marjan; VAN DER POL, Susanne; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; SOMERS, Veerle; DE VRIES, Helga E.; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
1542015Circulating Follicular Regulatory T Cells Are Defective in Multiple SclerosisDHAEZE, Tessa; PEELEN, Evelyn; Hombrouck, Anneleen; PEETERS, Liesbet; VAN WIJMEERSCH, Bart; LEMKENS, Nele; LEMKENS, Peter; SOMERS, Veerle; Lucas, Sophie; BROUX, Bieke; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
1552015Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosisJANSSENS, Kris; Van den Haute, C.; Baekelandt, Veerle; Lucas, S.; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HELLINGS, Niels; HENDRIKS, Jerome; SLAETS, Leen; SOMERS, VeerleJournal ContributionA1
1562015Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression indexDE BOCK, Laura; FRAUSSEN, Judith; Villar, Luisa M.; Alvarez-Cermeno, Jose C.; VAN WIJMEERSCH, Bart; van Pesch, Vincent; STINISSEN, Piet; SOMERS, VeerleJournal ContributionA1
1572015Overview of the management of relapsing-remitting multiple sclerosis and practical recommendationsGallo, P.; VAN WIJMEERSCH, BartJournal ContributionA1
1582015B cells from MS patients induce autoreactive Th1 and Th17 responsesFRAUSSEN, Judith; CLAES, Nele; HELLINGS, Niels; VAN WIJMEERSCH, Bart; STINISSEN, Piet; Hupperts, R.; SOMERS, VeerleJournal ContributionM
1592015Characterizing the impact of teriflunomide on adaptive immune cell subsets, repertoire and function in patients with relapsing-remitting MS: TERI-DYNAMICWiendl, H.; Gross, C. C.; Lindner, M.; Eschborn, M.; Weisser, L.; Posevitz-Fejfar, A.; Schulte-Mecklenbeck, A.; VAN WIJMEERSCH, Bart; Hupperts, R.; Lunven, C.; Brette, S.; Turner, T. J.; Klotz, L.Journal ContributionM
1602015Optimizing therapy early in multiple sclerosis: An evidence-based viewZiemssen, Tjalf; De Stefano, Nicola; Sormani, Maria Pia; VAN WIJMEERSCH, Bart; Wiendl, Heinz; Kieseier, Bernd C.Journal ContributionA1
show all